name: nivolumab
description: >
  Nivolumab is a full human IgG4 antibody that targets PD-1,
  programmed cell death protein 1, and is used in combination
  with protease inhibitors to activate T-cells to launch an immune
  response against the tumor. Used to combat cancer
therapeutic:
  - antibody
links:
  wikipedia: Nivolumab
  drugbank: DB09035
target:
  - host immune response
mechanism: Blocks PD-1 inhibitory signaling to T-cells
protein: PD-1
